Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bandar Aldawish
Observed name:
Bander Aldawish
Institution:
King Saud bin Abdulaziz University for Health Sciences
Observed institution:
King Saud bin Abdulaziz University for Health Sciences
ORCID:
0009-0002-2259-6135
Observed ORCID:
0009-0002-2259-6135
OpenAlex ID:
A5119540894
Bioactive Compounds From Saudi Arabian Fungi: A Systematic Review of Anticancer Potential
2025
·
Sahar Alghamdi
, Jehan Alamre
, et al.
·
Clinical Pharmacology Advances and Applications
·
2
PDF
Assessing Thrombotic Risk in Patients with HR+/HER2- Breast Cancer Receiving CDK4/6 Inhibitors: Insights from Real-World Data from the Middle East
2026
·
Nada Alsuhebany
, Ahmed Alanazi
, et al.
·
Breast Cancer Targets and Therapy
·
1
PDF
Assessing venous thromboembolism risk in HR+/HER2- breast cancer patients receiving CDK4/6 inhibitors: Insights from real-world data in the Middle East.
2025
·
Nada Alsuhebany
, Ahmed Alanazi
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
3
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type